The rivals seeking Bitcoin's crown

Cryptocurrencies fall into three groups

clock • 3 min read

As Bitcoin's price continues to pogo through extreme volatility, I find it more intriguing to assess its future by worrying less about price and, instead, analysing which of the 1000+ 'coins' available on exchanges could become the next big thing.

Cryptocurrencies have very different raison d'êtres, so it helps to divide them into three groups - Money, Platforms and Apps. Money Bitcoin falls into the first category of Money, as do many alternatives to Bitcoin. They are designed to be units of transaction primarily. If Bitcoin dies, it is likely coins from this category will take its place.  Three of the most popular at present are Monero, Litecoin and Dash, which try to improve over Bitcoin in areas like transaction speeds and privacy. Coins in this area should be decentralised with open source code so no one entity controls ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot